Karolinska Institutet
Browse

Synthetic pulmonary surfactant : effects of surfactant proteins B and C and their analogues

Download (1.64 MB)
thesis
posted on 2024-09-03, 00:25 authored by Andreas Almlén

Pulmonary surfactant is a lipid/protein mixture lining the air-liquid interface in the alveoli. Its main function is to lower surface tension during respiration and thereby prevent alveolar collapse at end-expiration. Surfactant deficiency, especially common in prematurely born babies, is the main cause of respiratory distress syndrome (RDS). This disease is treated with exogenous surfactant replacement using animal-derived modified natural surfactants. Production of these is quite expensive and the supply is limited. In addition there is a possible risk of transmitted infectious agents, which is why synthetic alternatives are under development.

We investigated the effect of an SP-C analogue, SP-C33, in phospholipids as a synthetic alternative. By circular dichroism and infrared spectroscopy we found that SP-C33 shows secondary structure and orientation in a phospholipid bilayer similar to SP-C. 1-2% of this analogue in a mixture of dipalmitoylphosphatidylcholine (DPPC)/palmitoyloleoylphosphatidylglycerol (POPG) (68:31 by weight) showed tidal volumes similar to those obtained by the modified natural surfactant Curosurf when used in ventilated prematurely born rabbits. When ventilated without positive end-expiratory pressure, SP-C33 surfactant shows lower lung gas volumes (LGV) compared to Curosurf, indicating that some component in the latter is needed to stabilize the lung at end-expiration. Our study shows that inclusion of both SP-C33 and SP-B, or an analogue thereof, significantly increases LGV. This indicates that SP-B and SP-C exerts different tasks in surfactant and that both proteins are necessary to obtain alveolar stability. The SP-B analogue Mini-B shows good surfactant activity both in vitro and in vivo and may be a good replacement in synthetic surfactant.

C-terminal modifications of SP-C33 do not alter its surfactant properties, indicating that mobility inside the membrane probably is not necessary for surfactant activity.

A synthetic surfactant consisting of 2% SP-C33 (by weight) in 80mg/ml DPPC/POPG (68:31 w/w) and an SP-B analogue, possibly Mini-B, may be a good replacement for modified natural surfactant in future treatment of neonatal RDS.

List of scientific papers

I. Johansson J, Some M, Linderholm BM, Almlén A, Curstedt T, Robertson B (2003). "A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits." J Appl Physiol 95(5): 2055-63. Epub 2003 Aug 1
https://pubmed.ncbi.nlm.nih.gov/12897027

II. Almlén A, Stichtenoth G, Robertson B, Johansson J, Curstedt T (2007). "Concentration dependence of a poly-leucine surfactant protein C analogue on in vitro and in vivo surfactant activity." Neonatology 92(3): 194-200. Epub 2007 Apr 27
https://pubmed.ncbi.nlm.nih.gov/17476119

III. Almlén A, Vandenbussche G, Linderholm B, Haegerstrand-Björkman M, Johansson J, Curstedt T (2010). "Alterations of the C-terminal end do not affect in vitro and in vivo activity of SP-C analogues." (Submitted)

IV. Almlén A, Stichtenoth G, Linderholm B, Haegerstrand-Björkman M, Robertson B, Johansson J, Curstedt T (2008). "Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome." J Appl Physiol 104(4): 1101-8. Epub 2008 Feb 14
https://pubmed.ncbi.nlm.nih.gov/18276900

V. Almlén A, Walther FJ, Waring AJ, Robertson B, Johansson J, Curstedt T (2010). "Synthetic Surfactant Based on Analogues of SP-B and SP-C Is Superior to Single-Peptide Surfactants in Ventilated Premature Rabbits." Neonatology 98(1): 91-99. [Epub ahead of print]
https://pubmed.ncbi.nlm.nih.gov/20110733

History

Defence date

2010-09-09

Department

  • Department of Molecular Medicine and Surgery

Publication year

2010

Thesis type

  • Doctoral thesis

ISBN

978-91-7409-966-9

Number of supporting papers

5

Language

  • eng

Original publication date

2010-08-19

Author name in thesis

Almlén, Andreas

Original department name

Department of Molecular Medicine and Surgery

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC